Information Provided By:
Fly News Breaks for March 12, 2018
CARA
Mar 12, 2018 | 07:11 EDT
H.C. Wainwright analyst Oren Livnat assumed coverage of Cara Therapeutics with a Buy rating and $22 price target.
News For CARA From the Last 2 Days
There are no results for your query CARA